Taysha Gene Therapies, Inc. (TSHA)
NASDAQ: TSHA · Real-Time Price · USD
6.30
-0.16 (-2.48%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Taysha Gene Therapies Market Cap
Taysha Gene Therapies has a market cap or net worth of $1.81 billion as of April 28, 2026. Its market cap has increased by 654.54% in one year.
Market Cap
1.81B
Enterprise Value
1.56B
1-Year Change
654.54%
Ranking
Category
Stock Price
$6.30
Market Cap Chart
Since the IPO on September 24, 2020, Taysha Gene Therapies's market cap has increased from $690.43M to $1.81B, an increase of 162.19%. That is a compound annual growth rate of 18.81%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Inhibrx Biosciences | 1.92B |
| AnaptysBio | 1.91B |
| Galapagos NV | 1.89B |
| Vericel | 1.88B |
| Pharvaris | 1.88B |
| Syndax Pharmaceuticals | 1.85B |
| Palvella Therapeutics | 1.84B |
| Recursion Pharmaceuticals | 1.84B |